{ "cik": 1447362, "cik_padded": "0001447362", "entityName": "CASTLE BIOSCIENCES INC", "fiscal_years": [ { "accn": "0001628280-26-012272", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 36021000.0, "cash": 116729000.0, "eps_diluted": -0.83, "free_cash_flow": 28326000.0, "net_income": -24158000.0, "operating_cash_flow": 64347000.0, "operating_income": -42810000.0, "revenue": 344229000.0, "stockholders_equity": 470873000.0, "total_assets": 578556000.0, "total_liabilities": 107683000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.22868799017994237, "net_margin": -0.07018002550627635, "operating_margin": -0.12436488500387823, "revenue_growth_yoy": 0.036618895470519684, "roa_avg2y": -0.0435361252704338, "roa_period_end": -0.04175568138607153, "roe_avg2y": -0.05213724279924205, "roe_period_end": -0.05130470424084626 } }, { "accn": "0001628280-26-012272", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 28326000.0, "cash": 119709000.0, "eps_diluted": 0.62, "free_cash_flow": 36540000.0, "net_income": 18245000.0, "operating_cash_flow": 64866000.0, "operating_income": 8670000.0, "revenue": 332069000.0, "stockholders_equity": 455835000.0, "total_assets": 531235000.0, "total_liabilities": 75400000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1654107297596718, "net_margin": 0.05494340031740391, "operating_margin": 0.026109031556694542, "revenue_growth_yoy": 0.5108604655395199, "roa_avg2y": 0.037061676357819366, "roa_period_end": 0.034344499138799216, "roe_avg2y": 0.04307617482623149, "roe_period_end": 0.04002544780457841 } }, { "accn": "0001628280-26-012272", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 13621000.0, "cash": 98841000.0, "eps_diluted": -2.14, "free_cash_flow": -19247000.0, "net_income": -57466000.0, "operating_cash_flow": -5626000.0, "operating_income": -67977000.0, "revenue": 219788000.0, "stockholders_equity": 391269000.0, "total_assets": 453340000.0, "total_liabilities": 62071000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.158640219388707, "net_margin": -0.2614610442790325, "operating_margin": -0.3092844013321928, "revenue_growth_yoy": 0.6038354045198812, "roa_avg2y": -0.12760736741244563, "roa_period_end": -0.12676137115630653, "roe_avg2y": -0.14540642368161696, "roe_period_end": -0.1468708228865563 } }, { "accn": "0001628280-26-012272", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5632000.0, "cash": 122948000.0, "eps_diluted": -2.58, "free_cash_flow": -47287000.0, "net_income": -67138000.0, "operating_cash_flow": -41655000.0, "operating_income": -72855000.0, "revenue": 137039000.0, "stockholders_equity": 399150000.0, "total_assets": 447329000.0, "total_liabilities": 48179000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1207039959914819, "net_margin": -0.48991892818832594, "operating_margin": -0.5316369792540809, "revenue_growth_yoy": 0.45654461391295104, "roa_avg2y": -0.14757209850302397, "roa_period_end": -0.1500864017311643, "roe_avg2y": -0.16559089395602364, "roe_period_end": -0.16820243016409872 } }, { "accn": "0001447362-25-000031", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3483000.0, "cash": 329633000.0, "eps_diluted": -1.24, "free_cash_flow": -22466000.0, "net_income": -31292000.0, "operating_cash_flow": -18983000.0, "operating_income": -40079000.0, "revenue": 94085000.0, "stockholders_equity": 411740000.0, "total_assets": 462572000.0, "total_liabilities": 50832000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12345655025015786, "net_margin": -0.33259286815114, "operating_margin": -0.42598713928894083, "revenue_growth_yoy": 0.5017797570591709, "roa_avg2y": -0.06939128506486307, "roa_period_end": -0.0676478472540491, "roe_avg2y": -0.07563651833204219, "roe_period_end": -0.07599941710788362 } }, { "accn": "0001447362-23-000038", "filed": "2023-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4751000.0, "cash": 409852000.0, "eps_diluted": -0.54, "free_cash_flow": 5114000.0, "net_income": -10284000.0, "operating_cash_flow": 9865000.0, "operating_income": -6542000.0, "revenue": 62649000.0, "stockholders_equity": 415691000.0, "total_assets": 439328000.0, "total_liabilities": 23637000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05686194793728996, "net_margin": -0.16415266005842072, "operating_margin": -0.10442305543584096, "revenue_growth_yoy": 0.20792441916514026, "roa_avg2y": -0.03678940533811267, "roa_period_end": -0.023408478403379708, "roe_avg2y": -0.04106995950511577, "roe_period_end": -0.024739530083643865 } }, { "accn": "0001447362-22-000045", "filed": "2022-02-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 937000.0, "cash": 98845000.0, "eps_diluted": -0.21, "free_cash_flow": 6078000.0, "net_income": 5277000.0, "operating_cash_flow": 7015000.0, "operating_income": 7328000.0, "revenue": 51865000.0, "stockholders_equity": 85113000.0, "total_assets": 119746000.0, "total_liabilities": 34633000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.40690611304971036, "net_margin": 0.1017449146823484, "operating_margin": 0.14128988720717248, "revenue_growth_yoy": 1.2761783551303432, "roa_avg2y": 0.07424499300040098, "roa_period_end": 0.04406827785479264, "roe_avg2y": 0.3697060987144008, "roe_period_end": 0.06199992950548095 } }, { "accn": "0001447362-21-000047", "filed": "2021-03-11", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 277000.0, "cash": 4479000.0, "eps_diluted": -5.33, "free_cash_flow": -12572000.0, "net_income": -6367000.0, "operating_cash_flow": -12295000.0, "operating_income": -3836000.0, "revenue": 22786000.0, "stockholders_equity": -56566000.0, "total_assets": 22405000.0, "total_liabilities": 32475000.0 }, "period_end": "2018-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.2794259633108049, "operating_margin": -0.16834898621960853, "roa_period_end": -0.28417763891988396, "roe_avg2y": 0.11914630837317665 } }, { "accn": "0001447362-20-000029", "filed": "2020-03-10", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -50311000.0 }, "period_end": "2017-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001628280-26-012272", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "8071", "sic_description": "Services-Medical Laboratories", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001447362.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001447362.json" }, "ticker": "CSTL" }